Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) EBT Margin (2016 - 2026)

Orthofix Medical has reported EBT Margin over the past 17 years, most recently at 11.19% for Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 1751.0% year-over-year to 11.19%, compared with a TTM value of 4.27% through Mar 2026, up 2328.0%, and an annual FY2025 reading of 0.3%, up 1687.0% over the prior year.
  • EBT Margin came in at 11.19% for Q1 2026, down from 41.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 90.23% in Q4 2023 to a low of 37.18% in Q1 2023.
  • Median EBT Margin over the past 5 years was 11.49% (2025), compared with a mean of 5.29%.
  • The sharpest move saw EBT Margin soared 10067bps in 2023, then plummeted -10835bps in 2024.
  • Over 5 years, EBT Margin stood at 10.44% in 2022, then soared by 965bps to 90.23% in 2023, then tumbled by -120bps to 18.12% in 2024, then surged by 329bps to 41.42% in 2025, then plummeted by -127bps to 11.19% in 2026.
  • Per Business Quant, the three most recent readings for OFIX's EBT Margin are 11.19% (Q1 2026), 41.42% (Q4 2025), and 11.49% (Q3 2025).